EUVIMEDObjevte EUVIMED
Open access

Automated Enzymatic Deglycosylation of Monoclonal Antibody with the SampleStream Platform

Troy D Fisher iD, Philip D Compton, Matthew T Robey iD, Ryan T Fellers, Kenneth R Durbin iD, Neil L Kelleher iD

Journal of the American Society for Mass Spectrometry · 2026

DOI: 10.1021/jasms.5c00242 ↗

At a glance

Journal article in Journal of the American Society for Mass Spectrometry, 2026. Written by Troy D Fisher and 5 co-authors. Institution: Proteomics Center of Excellence, Northwestern University, Evanston, Illinois 60208, United States. Major MEDLINE topics: Antibodies, Monoclonal, Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase. 20 references. The full text is freely available in PubMed Central. Funded by: NIGMS NIH HHS, National Institute of General Medical Sciences.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Engineered monoclonal antibodies have proven themselves as invaluable biotherapeutics used in clinics worldwide. In discovery, development, and production, it is essential that they are accurately validated to ensure their homogeneity, consistency, safety, and effectiveness, which are commonly conducted via mass spectrometric analysis. However, validation processes can be manual, time-consuming, and costly. One hindrance in the analytical workflow is the relatively long time required to deglycosylate native mAbs with PNGase F on the benchtop, which is usually done to reduce the spectral complexity, increase the ionization efficiency, and facilitate the identification of glycosylation sites. To circumvent this obstacle, a workflow on the SampleStream Platform was developed and optimized to automate in-channel PNGase F-mediated deglycosylation of native monoclonal antibody at unprecedented speed, accomplishing 86% deglycosylation in 3 min. The presented workflow offers a promising strategy to reduce discovery and development costs and streamline the characterization of antibody-based biopharmaceuticals.

Subjects

MeSH terms (MEDLINE)

Antibodies, MonoclonalPeptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine AmidaseGlycosylationWorkflowMass SpectrometryAnimalsHumansAutomation

Author keywords

Native deglycosylationPNGase Fbiotherapeuticsmonoclonal antibody

Substances

Antibodies, MonoclonalPeptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase

Authors and institutions

  • Proteomics Center of Excellence, Northwestern University, Evanston, Illinois 60208, United States.
  • Proteinaceous, Inc., Evanston, Illinois 60201, United States.
  • Integrated Protein Technologies, Carlsbad, California 92008, United States.
  • Department of Chemistry, Northwestern University, Evanston, Illinois 60208, United States.
  • Department of Biochemistry and Molecular Genetics, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, United States.

ORCID profiles: Troy D Fisher, Matthew T Robey, Kenneth R Durbin, Neil L Kelleher

Funding

  • NIGMS NIH HHS
  • National Institute of General Medical Sciences

Cite

APA

Fisher, T. D., Compton, P. D., Robey, M. T., Fellers, R. T., Durbin, K. R., & Kelleher, N. L. (2026). Automated Enzymatic Deglycosylation of Monoclonal Antibody with the SampleStream Platform. Journal of the American Society for Mass Spectrometry. https://doi.org/10.1021/jasms.5c00242

Vancouver

Fisher TD, Compton PD, Robey MT, Fellers RT, Durbin KR, Kelleher NL. Automated Enzymatic Deglycosylation of Monoclonal Antibody with the SampleStream Platform. Journal of the American Society for Mass Spectrometry. 2026. doi:10.1021/jasms.5c00242

BibTeX
@article{Fisher2026,
  author = {Fisher, Troy D and Compton, Philip D and Robey, Matthew T and Fellers, Ryan T and Durbin, Kenneth R and Kelleher, Neil L},
  title = {Automated Enzymatic Deglycosylation of Monoclonal Antibody with the SampleStream Platform},
  journal = {Journal of the American Society for Mass Spectrometry},
  year = {2026},
  doi = {10.1021/jasms.5c00242}
}
Start for free →